When non-small cell lung cancer (NSCLC) spreads beyond the lungs, it often metastasizes to the bones. Estimates suggest 20 to 30 percent of people with NSCLC have bone metastases at the time of ...

Metastatic cancer, the form of cancer that spreads from its original site to distant parts of the body, often provides warning signs long before diagnosis. These signals, frequently dismissed as ...

Bone cancer represents a serious medical condition that affects thousands of people each year, yet many individuals remain unfamiliar with its characteristics, symptoms, and treatment approaches.

The signs that thyroid cancer has spread can vary depending on where in the body it has traveled to. Thyroid cancers often spread to the nearby lymph nodes and the lungs, bone, brain, and liver. For ...

Bone metastasizing and/or bone growing malignancies are a high unmet medical need. In breast and prostate cancer, bone is the ...

BERLIN -- Administering bone-modifying agents (BMAs) every 24 weeks after long-term use was a safe and effective strategy for ...

Results suggest bone-protecting agents should be used in patients with metastatic castration-resistant prostate cancer and bone metastasis, especially in the era of androgen receptor pathway ...

Erleada plus ADT may provide limited benefits for mCSPC patients with fewer bone metastases, affecting PFS2 and OS outcomes. Baseline bone metastasis count could guide treatment optimization for mCSPC ...